Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock and Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Shares, Outstanding, Beginning Balance at Dec. 31, 2022		10,767	(541)
Beginning balance at Dec. 31, 2022	$ 39,825	$ 111,282	$ (5,364)		$ (66,093)
Net Income (Loss)	(2,858)				(2,858)
Stock-based compensation	1,874	$ 1,874
Common stock Issued through restricted stock awards		278
Common stock withheld related to net share settlement of equity awards, Share		(118)
Common stock withheld related to net share settlement of equity awards	(678)	$ (678)
Common stock issued under ESPP, Share		22
Common stock issued under ESPP, Value	137	$ 137
Ending balance at Mar. 31, 2023	38,300	$ 112,615	$ (5,364)		(68,951)
Shares, Outstanding, Ending Balance at Mar. 31, 2023		10,949	(541)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022		10,767	(541)
Beginning balance at Dec. 31, 2022	39,825	$ 111,282	$ (5,364)		(66,093)
Net Income (Loss)	(5,063)
Foreign currency translation adjustment	0
Ending balance at Jun. 30, 2023	37,079	$ 113,599	$ (5,364)		(71,156)
Shares, Outstanding, Ending Balance at Jun. 30, 2023		10,964	(541)
Shares, Outstanding, Beginning Balance at Mar. 31, 2023		10,949	(541)
Beginning balance at Mar. 31, 2023	38,300	$ 112,615	$ (5,364)		(68,951)
Net Income (Loss)	(2,205)				(2,205)
Stock-based compensation	968	$ 968
Common stock Issued through restricted stock awards		5
Common stock Issued through stock options, Share		12
Common stock Issued through stock options	28	$ 28
Common stock withheld related to net share settlement of equity awards, Share		(2)
Common stock withheld related to net share settlement of equity awards	(12)	$ (12)
Foreign currency translation adjustment	0
Ending balance at Jun. 30, 2023	37,079	$ 113,599	$ (5,364)		(71,156)
Shares, Outstanding, Ending Balance at Jun. 30, 2023		10,964	(541)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023		11,010	(541)
Beginning balance at Dec. 31, 2023	31,413	$ 115,295	$ (5,364)	$ 3	(78,521)
Net Income (Loss)	(2,455)				(2,455)
Stock-based compensation	1,087	$ 1,087
Common stock Issued through restricted stock awards		169
Common stock withheld related to net share settlement of equity awards, Share		(24)
Common stock withheld related to net share settlement of equity awards	(94)	$ (94)
Common stock issued under ESPP, Share		23
Common stock issued under ESPP, Value	76	$ 76
Foreign currency translation adjustment	(2)			(2)
Common stock Issued in connection with at-the-market offerings, net Share		124
Common stock Issued in connection with at-the-market offerings, net Value	488	$ 488
Ending balance at Mar. 31, 2024	30,513	$ 116,852	$ (5,364)	1	(80,976)
Shares, Outstanding, Ending Balance at Mar. 31, 2024		11,302
Shares, Outstanding, Beginning Balance at Dec. 31, 2023		11,010	(541)
Beginning balance at Dec. 31, 2023	31,413	$ 115,295	$ (5,364)	3	(78,521)
Net Income (Loss)	(4,968)
Foreign currency translation adjustment	(4)
Ending balance at Jun. 30, 2024	31,590	$ 120,444	$ (5,364)	(1)	(83,489)
Shares, Outstanding, Ending Balance at Jun. 30, 2024		11,842	(541)
Shares, Outstanding, Beginning Balance at Mar. 31, 2024		11,302
Beginning balance at Mar. 31, 2024	30,513	$ 116,852	$ (5,364)	1	(80,976)
Net Income (Loss)	(2,513)				(2,513)
Stock-based compensation	1,049	$ 1,049
Common stock Issued through restricted stock awards		27
Common stock Issued through stock options, Share		8
Common stock Issued through stock options	25	$ 25
Foreign currency translation adjustment	(2)			(2)
Common stock Issued in connection with at-the-market offerings, net Share		505
Common stock Issued in connection with at-the-market offerings, net Value	2,518	$ 2,518
Ending balance at Jun. 30, 2024	$ 31,590	$ 120,444	$ (5,364)	$ (1)	$ (83,489)
Shares, Outstanding, Ending Balance at Jun. 30, 2024		11,842	(541)